SCHEMBL21252087

SCHEMBL21252087

COc1cc(OC)c(Cl)c(-c2cc3cnc(N)cc3c(N3CCCC(OC)C3)n2)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.39
▸ MAOB P27338 1/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ FGFR4 P22455 3/20 0.36
▸ PIM1 P11309 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ PRKCB P05771 1/20 0.35
▸ PRKCA P17252 1/20 0.35
▸ PRKCH P24723 1/20 0.35
▸ PRKCE Q02156 1/20 0.35
▸ PRKCQ Q04759 1/20 0.35
▸ PRKCD Q05655 1/20 0.35
▸ PDE3B Q13370 3/20 0.34
▸ PDE3A Q14432 3/20 0.34
▸ PDE10A Q9Y233 3/20 0.34
▸ MAP3K12 Q12852 1/20 0.34
▸ CCR4 P51679 1/20 0.34
▸ ADRA1D P25100 2/20 0.33
▸ ADRA1B P35368 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21251783 0.95 PIM1 (0.36) MAP4K4MAOBHTR6FGFR4PIM1
SCHEMBL24488230 0.94 PDE10A (0.39) MAOBFGFR4PDE3BPDE3APDE10A
SCHEMBL21240510 0.91 MAOB (0.38) MAP4K4MAOBHTR6FGFR4PIM1
SCHEMBL21251762 0.90 FGFR4 (0.37) FGFR4PDE3BPDE3APDE10AMAP3K12
SCHEMBL21251868 0.90 MAOB (0.37) MAP4K4MAOBHTR6FGFR4PIM1
SCHEMBL20332035 0.89 PDE10A (0.37) MAOBFGFR4PDE3BPDE3APDE10A
SCHEMBL21252058 0.89 FGFR4 (0.40) MAP4K4FGFR4PDE3BPDE3APDE10A
SCHEMBL21252341 0.87 SMN1; SMN2 (0.43) FGFR4FGFR1FGFR2ALDH1A1SMN1; SMN2
SCHEMBL21252286 0.87 SMN1; SMN2 (0.40) FGFR4FGFR1FGFR2ALDH1A1SMN1; SMN2
SCHEMBL24488354 0.85 MAP4K4 (0.39) MAP4K4MAOBHTR6PIM1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-B1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF ABBISKO THERAPEUTICS CO LTD (CN) 2022-06-08 — — EP disclosed
EP-3524603-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2019-08-14 — — EP disclosed
Send feedback